Literature DB >> 222624

Localization and possible function of peptidergic neurons and their interactions with central catecholamine neurons, and the central actions of gut hormones.

K Fuxe, K Andersson, T Hökfelt, V Mutt, L Ferland, L F Agnati, D Ganten, S Said, P Eneroth, J A Gustafsson.   

Abstract

The localization of various neuropeptides is described in the gut and in the hypothalamus in the rat. Evidence is given for the presence of material resembling corticotropin-like intermediate peptide in arcuate and periarcuate neurons, projecting to various hypothalamic nuclei, limbic areas and the thalamus. beta-Endorphin and glucagon decrease dopamine turnover in the median eminence, while secretin increases dopamine turnover and vasoactive intestinal polypeptide (VIP) has no effect. beta-Endorphin, VIP, secretin, and glucagon all produce discrete changes in norepinephrine turnover in various hypothalamic nuclei. Mainly increases of norepinephrine turnover were observed. These catecholamine turnover changes appear to cause changes in the secretion of prolactin and growth hormone. The results therefore indicate that gut hormones and opioid peptides may act directly on the hypothalamus on specific types of receptors to participate in the control of hypothalamic functions such as control of hormone secretion from the anterior pituitary and of food intake. It seems possible that gastrointestinal peptides released from the gastrointestinal tract into the circulation under certain circumstances could reach the hypothalamus and modulate its activity via the above-mentioned mechanisms. It may therefore be speculated that disturbances in gastrointestinal functions could lead to pathological changes in food intake via modulation of hypothalamic activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222624

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  14 in total

Review 1.  Secretin: Should we revisit its metabolic outcomes?

Authors:  D H St-Pierre; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

Review 2.  Toxicity of metabolites to dopaminergic systems and the behavioural effects of organic solvents.

Authors:  A Mutti; I Franchini
Journal:  Br J Ind Med       Date:  1987-11

3.  Combined administration of secretin and oxytocin inhibits chronic colitis and associated activation of forebrain neurons.

Authors:  Martha G Welch; Muhammad Anwar; Christine Y Chang; Kara J Gross; David A Ruggiero; Hadassah Tamir; Michael D Gershon
Journal:  Neurogastroenterol Motil       Date:  2010-03-04       Impact factor: 3.598

4.  Ultrastructural investigation of ACTH immunoreactivity in arcuate and supraoptic nuclei of the rat.

Authors:  C Leranth; T H Williams; M Chretien; M Palkovits
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

5.  Effect of microionophoresis of met-enkephalin into various brain structures on the secretion of luteinizing and thyrotropic hormones.

Authors:  S F Mironov; V N Babichev
Journal:  Neurosci Behav Physiol       Date:  1985 Sep-Oct

6.  Brain effects of chronic IBD in areas abnormal in autism and treatment by single neuropeptides secretin and oxytocin.

Authors:  Martha G Welch; Thomas B Welch-Horan; Muhammad Anwar; Nargis Anwar; Robert J Ludwig; David A Ruggiero
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

7.  Ultrastructure of endocrine-like cells in lamina propria of human gastric mucosa.

Authors:  J Stachura; W J Krause; K J Ivey
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

8.  Secretin: hypothalamic distribution and hypothesized neuroregulatory role in autism.

Authors:  M G Welch; J D Keune; T B Welch-Horan; N Anwar; M Anwar; R J Ludwig; D A Ruggiero
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

9.  Identification, characterization, and distribution of secretin immunoreactivity in rat and pig brain.

Authors:  T L O'Donohue; C G Charlton; R L Miller; G Boden; D M Jacobowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

Review 10.  Secretin as a neuropeptide.

Authors:  Samuel S M Ng; W H Yung; Billy K C Chow
Journal:  Mol Neurobiol       Date:  2002-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.